Banque Cantonale Vaudoise Invests $917,000 in The Cooper Companies, Inc. $COO

Banque Cantonale Vaudoise bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the 4th quarter, Holdings Channel.com reports. The institutional investor bought 11,184 shares of the medical device company’s stock, valued at approximately $917,000.

Several other institutional investors also recently modified their holdings of COO. Bell Investment Advisors Inc grew its position in shares of Cooper Companies by 106.3% during the 3rd quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock worth $29,000 after buying an additional 219 shares during the period. CYBER HORNET ETFs LLC bought a new position in shares of Cooper Companies during the 2nd quarter valued at about $36,000. True Wealth Design LLC lifted its holdings in shares of Cooper Companies by 484.8% during the 4th quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock valued at $38,000 after purchasing an additional 383 shares in the last quarter. Cromwell Holdings LLC lifted its holdings in shares of Cooper Companies by 128.8% during the 4th quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock valued at $40,000 after purchasing an additional 273 shares in the last quarter. Finally, Board of the Pension Protection Fund bought a new position in shares of Cooper Companies during the 4th quarter valued at about $41,000. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Stock Down 0.5%

COO stock opened at $62.55 on Friday. The company has a current ratio of 1.34, a quick ratio of 0.79 and a debt-to-equity ratio of 0.22. The firm has a market capitalization of $12.20 billion, a PE ratio of 30.97, a PEG ratio of 1.62 and a beta of 0.89. The Cooper Companies, Inc. has a 1-year low of $58.89 and a 1-year high of $89.83. The business’s 50 day simple moving average is $66.92 and its 200 day simple moving average is $75.14.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share for the quarter, topping analysts’ consensus estimates of $1.03 by $0.07. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The business had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.02 billion. During the same period in the previous year, the firm earned $0.92 EPS. The firm’s revenue was up 6.2% compared to the same quarter last year. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. As a group, research analysts anticipate that The Cooper Companies, Inc. will post 4.62 EPS for the current year.

Wall Street Analysts Forecast Growth

COO has been the topic of several recent analyst reports. Barclays lifted their price objective on Cooper Companies from $98.00 to $103.00 and gave the company an “overweight” rating in a report on Friday, March 6th. Citigroup cut their target price on Cooper Companies from $88.00 to $87.00 and set a “neutral” rating on the stock in a research note on Friday, March 6th. William Blair upgraded Cooper Companies to a “strong-buy” rating in a research note on Friday, January 30th. Rothschild & Co Redburn cut Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 target price on the stock. in a research note on Wednesday, March 4th. Finally, Needham & Company LLC boosted their target price on Cooper Companies from $99.00 to $101.00 and gave the company a “buy” rating in a research note on Friday, March 6th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $90.79.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.